Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 52.00%1.68B | 21.32%1.14B | 114.07%578M | 83.48%3.39B | 182.68%1.08B | -18.55%1.1B | 51.78%938M | 153.36%270M | -49.63%1.85B | -58.94%381M |
| Net income from continuing operations | 388.21%1.12B | 15.60%1.13B | 2.29%849M | 59.53%2.88B | 13.86%838M | 24.46%229M | 194.59%981M | 50.64%830M | -40.01%1.8B | 74.82%736M |
| Operating gains losses | 9.88%-547M | -153.33%-114M | -150.00%-115M | -55.98%-613M | 116.96%106M | -452.91%-607M | -117.05%-45M | 78.70%-46M | -577.59%-393M | -862.20%-625M |
| Securities amortization | -41.94%-44M | -35.71%-38M | -8.82%-37M | -254.05%-131M | -11.76%-38M | -121.43%-31M | -566.67%-28M | -780.00%-34M | -130.83%-37M | -409.09%-34M |
| Derivatives unrealized gains and losses | 10.76%247M | ---- | -67.44%28M | 325.35%302M | -65.29%42M | 471.67%223M | ---- | 115.00%86M | 163.39%71M | 450.00%121M |
| Remuneration paid in stock | 50.00%45M | 28.21%50M | 22.22%22M | 12.50%135M | 50.00%48M | 30.43%30M | 5.41%39M | -35.71%18M | -21.05%120M | -28.89%32M |
| Other non cash items | -400.00%-65M | -103.03%-2M | 63.10%-62M | -243.68%-125M | -1,166.67%-96M | -140.63%-13M | 1,750.00%66M | -625.00%-168M | -15.53%87M | 1,000.00%9M |
| Change in working capital | -28.12%869M | 150.45%56M | 90.88%-26M | 416.96%916M | 128.85%119M | 42.07%1.21B | 11.20%-111M | 73.29%-285M | -216.06%-289M | -76.36%52M |
| -Change in other current assets | -119.05%-16M | 167.57%25M | 20.19%-83M | -840.00%-74M | -129.82%-17M | 950.00%84M | -54.17%-37M | -235.48%-104M | 123.81%10M | 137.50%57M |
| -Change in other current liabilities | 262.64%148M | 1.10%-180M | -113.33%-10M | 82.85%-202M | 122.22%12M | -727.27%-91M | 0.55%-182M | 108.06%75M | -1,491.89%-1.18B | -154.55%-54M |
| Dividends received (cash flow from operating activities) | 50.00%9M | -30.00%7M | -60.87%9M | 12.82%44M | -68.75%5M | 0.00%6M | -16.67%10M | 360.00%23M | -20.41%39M | 23.08%16M |
| Tax refund paid | -31.93%-157M | -8.33%-169M | 16.37%-281M | -386.93%-745M | -76.32%-134M | -950.00%-119M | -155.74%-156M | -1,020.00%-336M | 62.50%-153M | -171.43%-76M |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 52.00%1.68B | 21.32%1.14B | 114.07%578M | 83.48%3.39B | 182.68%1.08B | -18.55%1.1B | 51.78%938M | 153.36%270M | -49.63%1.85B | -58.94%381M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 18.72%-964M | -602.90%-485M | -114.75%-50M | 19.50%-1.61B | -10.97%-698M | 7.20%-1.19B | 77.45%-69M | 62.98%339M | 26.98%-2.01B | 16.80%-629M |
| Net intangibles purchase and sale | -16.51%-127M | 28.57%-85M | 10.10%-89M | 6.33%-429M | 10.53%-102M | 10.66%-109M | -6.25%-119M | 10.00%-99M | -11.44%-458M | 4.20%-114M |
| Net business purchase and sale | -456.67%-167M | -202.78%-74M | -361.90%-291M | 95.48%-45M | 97.41%-24M | 77.10%-30M | 928.57%72M | -212.50%-63M | -221.19%-995M | -2,548.57%-927M |
| Net investment purchase and sale | 36.01%-670M | -1,381.82%-326M | -34.13%330M | -106.52%-1.14B | -238.83%-572M | -2.15%-1.05B | 89.05%-22M | 91.22%501M | 82.51%-552M | 168.44%412M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 18.72%-964M | -602.90%-485M | -114.75%-50M | 19.50%-1.61B | -10.97%-698M | 7.20%-1.19B | 77.45%-69M | 62.98%339M | 26.98%-2.01B | 16.80%-629M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -21.45%-436M | 2.38%-451M | 57.97%-290M | -724.92%-2.01B | -385.29%-495M | -174.17%-359M | -39.58%-462M | -355.56%-690M | 114.54%321M | 79.48%-102M |
| Net issuance payments of debt | -115.66%-26M | 38.38%-61M | 104.62%19M | -218.58%-568M | -265.93%-224M | 9.93%166M | -130.23%-99M | -274.15%-411M | 156.02%479M | 146.08%135M |
| Net common stock issuance | -1,850.00%-156M | -2.46%-125M | -19.57%-55M | -148.23%-204M | -550.00%-39M | -101.47%-8M | -90.63%-122M | 13.21%-46M | 261.45%423M | 0.00%-6M |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | ---- | --0 | 102.74%296M | --0 |
| Cash dividends paid | -9.01%-254M | -8.61%-265M | -9.01%-254M | -10.56%-953M | -8.48%-243M | -9.39%-233M | -12.96%-244M | -11.48%-233M | -13.12%-862M | -17.28%-224M |
| Proceeds from stock option exercised by employees | ---- | --0 | ---- | --11M | --0 | --0 | --11M | ---- | --0 | --0 |
| Net other financing charges | ---- | ---- | ---- | -1,846.67%-292M | --0 | ---284M | 0.00%-8M | ---- | 96.84%-15M | 0.00%-7M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -21.45%-436M | 2.38%-451M | 57.97%-290M | -724.92%-2.01B | -385.29%-495M | -174.17%-359M | -39.58%-462M | -355.56%-690M | 114.54%321M | 79.48%-102M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.08%1.44B | 13.24%1.25B | -14.86%997M | 15.94%1.17B | -29.26%1.08B | 55.23%1.52B | 11.30%1.1B | 15.94%1.17B | -55.62%1.01B | 16.87%1.53B |
| Current changes in cash | 162.08%275M | -50.37%202M | 393.83%238M | -243.83%-233M | 66.86%-116M | -179.25%-443M | 2,242.11%407M | -189.29%-81M | 112.58%162M | -7.69%-350M |
| Effect of exchange rate changes | 109.09%23M | -360.00%-13M | 7.69%14M | 6,000.00%59M | 400.00%30M | 375.00%11M | 25.00%5M | 44.44%13M | -104.55%-1M | -140.00%-10M |
| End cash Position | 60.30%1.74B | -5.08%1.44B | 13.24%1.25B | -14.86%997M | -14.86%997M | -29.26%1.08B | 55.23%1.52B | 11.30%1.1B | 15.94%1.17B | 15.94%1.17B |
| Free cash flow | 55.89%1.55B | 28.57%1.05B | 185.96%489M | 113.11%2.96B | 265.17%975M | -19.33%993M | 61.86%819M | 127.76%171M | -57.34%1.39B | -67.00%267M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.